相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association between fat mass, adipose tissue, fat fraction per adipose tissue, and metabolic risks: a cross-sectional study in normal, overweight, and obese adults
Mark Huebers et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2019)
The Role of Diet in Patients with Metabolic Syndrome
Paloma Almeda-Valdes et al.
CURRENT MEDICINAL CHEMISTRY (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Current and future pharmacological therapies for NAFLD/NASH
Yoshio Sumida et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Cardiovascular and Metabolic Heterogeneity of Obesity Clinical Challenges and Implications for Management
Ian J. Neeland et al.
CIRCULATION (2018)
Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes
Fernando Bril et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Chun Kit Hung et al.
CLINICS IN LIVER DISEASE (2018)
Pharmacotherapy for NASH: Current and emerging
Monica A. Konerman et al.
JOURNAL OF HEPATOLOGY (2018)
Effects of Oleacein on High-Fat Diet-Dependent Steatosis, Weight Gain, and Insulin Resistance in Mice
Giovanni Enrico Lombardo et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Is obesity rather than the dietary supplement used for weight reduction the cause of liver injury?
Rolf Teschke et al.
JGH OPEN (2018)
Treatment of NAFLD with diet, physical activity and exercise
Manuel Romero-Gómez et al.
JOURNAL OF HEPATOLOGY (2017)
Therapies in non-alcoholic steatohepatitis (NASH)
Abdul M. Oseini et al.
LIVER INTERNATIONAL (2017)
Emerging therapies for NASH - the future is now
Andreas Geier et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2017)
Management Strategies for Liver Fibrosis
Alejandra Altamirano-Barrera et al.
ANNALS OF HEPATOLOGY (2017)
Recent Trends in Endoscopic Bariatric Therapies
Hyuk Soon Choi et al.
CLINICAL ENDOSCOPY (2017)
Bile Acids in Nonalcoholic Fatty Liver Disease: New Concepts and Therapeutic Advances
Vania Cruz-Ramon et al.
ANNALS OF HEPATOLOGY (2017)
The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes
Jose Alberto Gonzalez-Regueiro et al.
ANNALS OF HEPATOLOGY (2017)
Non-alcoholic fatty liver disease: An expanded review
Mark Benedict et al.
WORLD JOURNAL OF HEPATOLOGY (2017)
Association between caffeine consumption and nonalcoholic fatty liver disease: a systemic review and meta-analysis
Huafeng Shen et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2016)
Fatty acid metabolism and the basis of brown adipose tissue function
Maria Calderon-Dominguez et al.
ADIPOCYTE (2016)
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus A Randomized Trial
Kenneth Cusi et al.
ANNALS OF INTERNAL MEDICINE (2016)
Molecular Pathogenesis of NASH
Alessandra Caligiuri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
Manoela Mota et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome
Nancy E. Aguilar-Olivos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Management of NAFLD: a stage-based approach
Mary E. Rinella et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD
Newaz Hossain et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2016)
Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
Xi-Xi He et al.
PLOS ONE (2016)
Recent insights on the role of cholesterol in non-alcoholic fatty liver disease
Graciela Arguello et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Current efforts and trends in the treatment of NASH
Vlad Ratziu et al.
JOURNAL OF HEPATOLOGY (2015)
Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity
Kavya Anjani et al.
JOURNAL OF HEPATOLOGY (2015)
Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population
Shira Zelber-Sagi et al.
TRANSLATIONAL RESEARCH (2015)
Standard short-term diet ameliorates the lipid profile altered by a fructose-rich diet in rats
L. T. Cambri et al.
JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE (2015)
The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis
Chiara Saponaro et al.
NUTRIENTS (2015)
Physiology and pathophysiology of liver lipid metabolism
Francesca Romana Ponziani et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2015)
New Evidence for the Role of Ceramide in the Development of Hepatic Insulin Resistance
Karolina Konstantynowicz-Nowicka et al.
PLOS ONE (2015)
Ceramide as a Mediator of Non-Alcoholic Fatty Liver Disease and Associated Atherosclerosis
Takhar Kasumov et al.
PLOS ONE (2015)
Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus
Surapon Tangvarasittichai
WORLD JOURNAL OF DIABETES (2015)
Non-alcoholic fatty liver disease in 2015
Monjur Ahmed
WORLD JOURNAL OF HEPATOLOGY (2015)
Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis
Licia Polimeni et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients
Xiaoli Pan et al.
ENDOCRINE (2015)
Recent advances in the development of farnesoid X receptor agonists
Ahmad H. Ali et al.
ANNALS OF TRANSLATIONAL MEDICINE (2015)
Plasma membrane phospholipase A2 controls hepatocellular fatty acid uptake and is responsive to pharmacological modulation: implications for nonalcoholic steatohepatitis
Wolfgang Stremmel et al.
FASEB JOURNAL (2014)
Oxysterols induce mitochondrial impairment and hepatocellular toxicity in non-alcoholic fatty liver disease
Bellanti Francesco et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Ceramides and Glucosylceramides Are Independent Antagonists of Insulin Signaling
Jose A. Chavez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent
Lay T. Gan et al.
JOURNAL OF HEPATOLOGY (2014)
Fish-Oil Fat Emulsion Supplementation Reduces the Risk of Retinopathy in Very Low Birth Weight Infants: A Prospective, Randomized Study
Dorota Pawlik et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2014)
c-Jun N-Terminal Kinase 1/c-Jun Activation of the p53/MicroRNA 34a/Sirtuin 1 Pathway Contributes to Apoptosis Induced by Deoxycholic Acid in Rat Liver
Duarte M. S. Ferreira et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Bariatric Surgery versus Intensive Medical Therapy for Diabetes REPLY
Philip R. Schauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Developmental origins of nonalcoholic fatty liver disease
David E. Brumbaugh et al.
PEDIATRIC RESEARCH (2014)
Evaluation of Dietary Effects on Hepatic Lipids in High Fat and Placebo Diet Fed Rats by In Vivo MRS and LC-MS Techniques
Jadegoud Yaligar et al.
PLOS ONE (2014)
Validation of Anthropometric Indices of Adiposity against Whole-Body Magnetic Resonance Imaging - A Study within the German European Prospective Investigation into Cancer and Nutrition (EPIC) Cohorts
Jasmine Neamat-Allah et al.
PLOS ONE (2014)
Proteomic analysis of liver mitochondria from rats with nonalcoholic steatohepatitis
Lin Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
The role of n-6 and n-3 polyunsaturated fatty acids in the manifestation of the metabolic syndrome in cardiovascular disease and non-alcoholic fatty liver disease
Jessica Monteiro et al.
FOOD & FUNCTION (2014)
Bariatric Surgery versus Intensive Medical Therapy for Diabetes-3-Year Outcomes
Philip R. Schauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Common Features of the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease
Paloma Almeda-Valdes et al.
REVIEWS ON RECENT CLINICAL TRIALS (2014)
Fatty acid transporters involved in the palmitate and oleate induced insulin resistance in primary rat hepatocytes
A. Chabowski et al.
ACTA PHYSIOLOGICA (2013)
The mechanical properties of human adipose tissues and their relationships to the structure and composition of the extracellular matrix
Nadia Alkhouli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Insulin signalling mechanisms for triacylglycerol storage
M. P. Czech et al.
DIABETOLOGIA (2013)
Aquaporin-10 Represents an Alternative Pathway for Glycerol Efflux from Human Adipocytes
Umberto Laforenza et al.
PLOS ONE (2013)
Caffeine is protective in patients with non-alcoholic fatty liver disease
A. Birerdinc et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis
Keisuke Kakisaka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial
Carmela Loguercio et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
Kenneth Cusi
GASTROENTEROLOGY (2012)
Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study
Yin-Mei Lee et al.
GASTROINTESTINAL ENDOSCOPY (2012)
Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis
Jeffrey W. Molloy et al.
HEPATOLOGY (2012)
Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease
Anita Pathil et al.
HEPATOLOGY (2012)
Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
Romina Lomonaco et al.
HEPATOLOGY (2012)
Lipotoxicity in NASH
Michael Fuchs et al.
JOURNAL OF HEPATOLOGY (2012)
Gut-liver axis: The impact of gut microbiota on non alcoholic fatty liver disease
D. Compare et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2012)
The Efficacy of Licorice Root Extract in Decreasing Transaminase Activities in Non-alcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial
Ali Akbar Hajiaghamohammadi et al.
PHYTOTHERAPY RESEARCH (2012)
Role of ceramides in nonalcoholic fatty liver disease
Mangesh Pagadala et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH
Meir Mizrahi et al.
JOURNAL OF INFLAMMATION RESEARCH (2012)
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
Giovanni Musso et al.
ANNALS OF MEDICINE (2011)
A Review of the Mammalian Unfolded Protein Response
Anirikh Chakrabarti et al.
BIOTECHNOLOGY AND BIOENGINEERING (2011)
Interruption of triacylglycerol synthesis in the endoplasmic reticulum is the initiating event for saturated fatty acid-induced lipotoxicity in liver cells
Michalis D. Mantzaris et al.
FEBS JOURNAL (2011)
Oxidative stress, insulin signaling, and diabetes
Justin L. Rains et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Association Between Composition of the Human Gastrointestinal Microbiome and Development of Fatty Liver With Choline Deficiency
Melanie D. Spencer et al.
GASTROENTEROLOGY (2011)
Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents The TONIC Randomized Controlled Trial
Joel E. Lavine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
Ralph A. DeFronzo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Nutrition and physical activity in NAFLD: An overview of the epidemiological evidence
Shira Zelber-Sagi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Obesity and bariatrics for the endoscopist: new techniques
Barham K. Abu Dayyeh et al.
Therapeutic Advances in Gastroenterology (2011)
CHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosis
Sophie C. Cazanave et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Fatty liver and lipotoxicity
Michael Trauner et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Lipid homeostasis, lipotoxicity and the metabolic syndrome
Roger H. Unger et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Newly diagnosed diabetes mellitus as a risk factor for serious liver disease
Liane Porepa et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2010)
Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects
Manoj Mathew et al.
CARDIOVASCULAR DIABETOLOGY (2010)
Surgical Treatment of Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease
R. A. Weiner
DIGESTIVE DISEASES (2010)
The Natural History of Non-Alcoholic Fatty Liver Disease
Stephen Caldwell et al.
DIGESTIVE DISEASES (2010)
Diversity in Antioxidant Response Enzymes in Progressive Stages of Human Nonalcoholic Fatty Liver Disease
Rhiannon N. Hardwick et al.
DRUG METABOLISM AND DISPOSITION (2010)
Coffee Reduces Liver Damage in a Rat Model of Steatohepatitis: The Underlying Mechanisms and the Role of Polyphenols and Melanoidins
Paola Vitaglione et al.
HEPATOLOGY (2010)
Clinical, Laboratory and Histological Associations in Adults with Nonalcoholic Fatty Liver Disease
Brent A. Nettschwander-Tetri et al.
HEPATOLOGY (2010)
Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis
Yuko Akazawa et al.
JOURNAL OF HEPATOLOGY (2010)
A Silybin-Phospholipid Complex Prevents Mitochondrial Dysfunction in a Rodent Model of Nonalcoholic Steatohepatitis
Gaetano Serviddio et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Effects of Hepatic Triglyceride Content on Myocardial Metabolism in Type 2 Diabetes
Luuk J. Rijzewijk et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Lipid-induced insulin resistance: unravelling the mechanism
Varman T. Samuel et al.
LANCET (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A 12-Week Aerobic Exercise Program Reduces Hepatic Fat Accumulation and Insulin Resistance in Obese, Hispanic Adolescents
Gert-Jan van der Heijden et al.
OBESITY (2010)
Milk Thistle in Liver Diseases: Past, Present, Future
Ludovico Abenavoli et al.
PHYTOTHERAPY RESEARCH (2010)
Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials
Markus Schuerks et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Microbes in Gastrointestinal Health and Disease
Andrew S. Neish
GASTROENTEROLOGY (2009)
Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers The Selenium and Vitamin E Cancer Prevention Trial ( SELECT)
Scott M. Lippman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease ROLE OF STEAROYL-CoA DESATURASE
Zheng Zheng Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH
Francisco Caballero et al.
JOURNAL OF HEPATOLOGY (2009)
Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal
Naim Alkhouri et al.
Expert Review of Gastroenterology & Hepatology (2009)
Obesity and Free Fatty Acids
Guenther Boden
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2008)
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
Janus P. Ong et al.
JOURNAL OF HEPATOLOGY (2008)
Adipose-derived stem cells: Isolation, expansion and differentiation
Bruce A. Bunnell et al.
METHODS (2008)
Obesity: the hormonal milieu
Anne Lenz et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2008)
An updated systematic review with meta-analysis for the clinical evidence of silymarin
Reinhard Saller et al.
FORSCHENDE KOMPLEMENTARMEDIZIN (2008)
Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes
Myoung Sook Han et al.
JOURNAL OF LIPID RESEARCH (2008)
Omega 3 - Omega 6: What is right for the liver?
Ashraf Mohammad El-Badry et al.
JOURNAL OF HEPATOLOGY (2007)
A lipidomic analysis of nonalcoholic fatty liver disease
Puneet Puri et al.
HEPATOLOGY (2007)
Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis
Fernando J. Barreyro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Cardiac steatosis in diabetes mellitus -: A 1H-magnetic resonance spectroscopy study
Jonathan M. McGavock et al.
CIRCULATION (2007)
Abdominal visceral and subcutaneous adipose tissue compartments - Association with metabolic risk factors in the Framingham Heart Study
Caroline S. Fox et al.
CIRCULATION (2007)
Review article: Possible beneficial effects of coffee on liver disease and function
I. S. H. Cadden et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Pediatric nonalcoholic fatty liver disease (NAFLD): A growing problem?
Eve A. Roberts
JOURNAL OF HEPATOLOGY (2007)
Adipose tissue expandability in the maintenance of metabolic homeostasis
Sarah L. Gray et al.
NUTRITION REVIEWS (2007)
Obesity, inflammation, and insulin resistance
Steven E. Shoelson et al.
GASTROENTEROLOGY (2007)
Abnormal lipid and glucose metabolism in obesity: Implications for nonalcoholic fatty liver disease
Samir Parekh et al.
GASTROENTEROLOGY (2007)
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
F. Lirussi et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2007)
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
Kanji Yamaguchi et al.
HEPATOLOGY (2007)
Triacylglycerol metabolism in adipose tissue
Mayam Ahmadian et al.
FUTURE LIPIDOLOGY (2007)
Silybin and silymarin - New and emerging applications in medicine
Radek Gazak et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Adipose tissue-derived factors: Impact on health and disease
Maria E. Trujillo et al.
ENDOCRINE REVIEWS (2006)
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Renata Belfort et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Myocardial triglyceride content and epicardial fat mass in human obesity:: Relationship to left ventricular function and serum free fatty acid levels
Mikko Kankaanpaa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Mattias Ekstedt et al.
HEPATOLOGY (2006)
A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease
Shira Zelber-Sagi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Mechanisms of liver injury.: I.: TNF-α-induced liver injury:: role of IKK, JNK, and ROS pathways
RF Schwabe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss - An update of the 1997 American Heart Association Scientific Statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism
P Poirier et al.
CIRCULATION (2006)
Specific inhibition of hormone-sensitive lipase improves lipid profile while reducing plasma glucose
TH Claus et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Dose-response effect of elevated plasma free fatty acid on insulin signaling
R Belfort et al.
DIABETES (2005)
Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality
ER Miller et al.
ANNALS OF INTERNAL MEDICINE (2005)
Toll-like receptors in innate immunity
K Takeda et al.
INTERNATIONAL IMMUNOLOGY (2005)
Molecular mediators of hepatic steatosis and liver injury
JD Browning et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease
LA Videla et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Death receptor signals to mitochondria
R Khosravi-Far et al.
CANCER BIOLOGY & THERAPY (2004)
Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery
C Beymer et al.
ARCHIVES OF SURGERY (2003)
Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal
K Lauber et al.
CELL (2003)
Adipose tissue quantification by imaging methods: A proposed classification
W Shen et al.
OBESITY RESEARCH (2003)
Tumor necrosis factor-α-associated lysosomal permeabilization is cathepsin B dependent
NW Werneburg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2002)
Plasma transforming growth factor-β1 level and efficacy of α-tocopherol in patients with non-alcoholic steatohepatitis:: a pilot study
T Hasegawa et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Fish oil (n-3) polyunsaturated fatty acids beneficially affect biliary cholesterol nucleation time in obese women losing weight
N Méndez-Sánchez et al.
JOURNAL OF NUTRITION (2001)
The use of silymarin in the treatment of liver diseases
R Saller et al.
DRUGS (2001)
Nonalcoholic steatohepatitis: Definition and pathology
EM Brunt
SEMINARS IN LIVER DISEASE (2001)
分享论文
